Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are commonly used
diabetes and obesity medications but have been associated with gastrointestinal (GI) …

Novel genetic risk markers have helped us to advance the field of cardiovascular
epidemiology and refine our current understanding and risk stratification paradigms. The …

Objectives To highlight the use of calibration weighting to improve the precision of estimates
obtained from All of Us data and increase the return of value to communities from the All of …

Background Representativeness in clinical trials (CT) serves as a metric of access to
healthcare and reflects differences that may determine differential efficacy of medical …

Puerto Ricans are underrepresented in genetic research. This underrepresentation denies
Puerto Ricans the benefit from therapeutic developments that could mitigate health …

Background There are increasing concerns that participants in health research in the UK are
not representative of the UK population, risking widening health inequities. However …

Background Evidence on effective approaches for the recruitment of diverse populations
remains limited. This study aimed to assess whether a co-developed study information video …

Aim: This study aimed to investigate how demographic factors such as race, age, sex and
ethnicity can impact hip circumference (HC) and waist circumference (WC) in patients with …

Introduction Due to the recent advent of gene-targeted retinal therapies, the clinical value of
high-yield genetic testing for inherited retinal dystrophies (IRDs) has increased …

Introduction The increasing aging population raises significant concerns about the ability of
individuals to age healthily, avoiding chronic diseases and maintaining cognitive and …